METASTATIC PROSTATE ADENOCARCINOMA
Clinical trials for METASTATIC PROSTATE ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PROSTATE ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC PROSTATE ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising prostate cancer combo study halted early
Disease control TerminatedThis early-stage trial tested whether adding an immunotherapy drug called vudalimab to standard hormone therapy or chemotherapy could help men with prostate cancer that has spread. Only 4 people took part before the study was stopped. The main goals were to check safety and see i…
Matched conditions: METASTATIC PROSTATE ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated May 26, 2026 08:35 UTC
-
Experimental drug targets Hard-to-Treat prostate cancer in bone
Disease control TerminatedThis study tested the drug erdafitinib in 11 men with advanced prostate cancer that kept growing despite hormone therapy and had spread to the bones. The goal was to see if erdafitinib could help control the cancer by blocking certain growth signals. Researchers also looked at bl…
Matched conditions: METASTATIC PROSTATE ADENOCARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 08:28 UTC
-
Bone pain trial halted after enrolling only one patient
Symptom relief TerminatedThis study tested a radioactive drug called Sn-117m-DTPA to see if it could reduce bone pain in men with prostate cancer that had spread to their bones. Only one person enrolled before the study was stopped early. The goal was to measure pain relief over several weeks, but no con…
Matched conditions: METASTATIC PROSTATE ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Symptom relief
Last updated May 19, 2026 12:00 UTC